| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.009 |